Bravo Pharma Diagnostic Labs and Clinics
Bravo Pharma is working with leading healthcare institutions and backend support from prestigious hospitals, comprehensive diagnostics laboratories and reference laboratories for oncological tests. The laboratories and clinics follow the latest standards in healthcare both in terms of technical capacities as well as client friendliness
Bravo Pharma believes in connected healthcare solutions. We are focused on the implementation of predictive, preventive and personalized medicine combining knowledge and skills of different countries and making healthcare accessible for our clients regardless of the country of residence.
Bravo Pharma has set up a comprehensive diagnostic center in Uzbekistan in association with leading diagnostic centres of India and Europe.
Bravo Pharma has developed a reference laboratory in the field of oncology and more recently a multi-platform pathology laboratory with main focus on molecular pathology and surgical pathology services.
Our service
| Sr.No | TEST CODE | TEST NAME | METHOD | SPECIMEN | SPECIMEN VOL | TEMPERATURE | FREQUENCY | REPORTED |
|---|---|---|---|---|---|---|---|---|
| 1 | 8825 | 1,25 DIHYDROXY VITAMIN D3 | RADIO IMMUNOASSAY | SERUM FASTING | 3.0 ML (2.0 ML) | "2-8 °C (24 hrs), F (> 24 hrs)" | 1,3,5: 1300 HRS | NEXT DAY |
| 2 | 6020F | 14 Q32 / IGH GENE REARRANGEMENT | FISH | BONE MARROW HEPARIN / WHOLE BLOOD HEPARIN + CLINICAL HISTORY. SPECIMEN TO REACH US within 48 hrs AF | 3.0 ML ( 2.0 ML) | "A" | DAILY:1200 HRS | 5th Day |
| 3 | 3311 | 17-ALPHA HYDROXYPROGESTERONE (Neonatal Screening) | ENZYME IMMUNOASSAY | DRY BLOOD SPOT (With complete CLINICAL HISTORY form including birth date & birth time.) | 2.0 NOs (1.0 NOs) | "2-8 °C (14 days)" | 1,4:1100 HRS | NEXT DAY |
| 4 | 3313 | 17-ALPHA- HYDROXYPROGESTERONE | CHROMATOGRAPHY / SPECTROPHOTOMETRY | URINE -24 HOURS (Collected in 10 ML conc HCL; Mention 24 hrs. total volume on TRF) (Age & Sex of the | 15.0 ML (10.0 ML) | "2-8 °C (15 days)" | 6: 1100 HRS | SAME DAY |
| 5 | 3190 | 17-ALPHA- HYDROXYPROGESTERONE | RADIO IMMUNOASSAY | SERUM (Age & Sex required) | 0.5 ML (0.2 ML) | "2-8 °C (4 days), F (>4days)" | 2,4: 1300 HRS | SAME DAY |
| 6 | 7376 | 1p/ 19q deletion for Oligodendrogliomas by FISH FISH | FISH | 1 Paraffin Block (malignant tissue embedded) and 1 hematoxylin-and-eosin stained slide. ( Paraffin e | 1+1 | "AMBIENT" | DAILY:1200HRS | 6TH DAY |
| 7 | 8823 | 25-HYDROXY VITAMIN D | ECLIA | SERUM Fasting | 1.0 ML (0.1 ML) | "2-8 °C (48 HRS), F (> 48 HRS AT -20 DEGREE C)" | DAILY: 1130 HRS | SAME DAY |
| 8 | 9952 | 5-HYDROXY INDOLE ACETIC ACID | ENZYME IMMUNOASSAY | 24HRS URINE TO BE STRICTLY COLLECTED IN 15ML OF 6N HCL. * WHILE COLLECTING 24HRS URINE SPECIMEN, THE | 20.0 ML (10.0 ML) | "FROZEN STRICTLY" | 2nd & 4th TUESDAY : 1000HRS | NEXT DAY |
| 9 | 5110N | ABSOLUTE NEUTROPHIL COUNT | CELL COUNTER / MICROSCOPY | WB-EDTA + DIRECT BLOOD SMEAR | 3.0 ML (2.0) ML + 2 SMEARS | "A" | DAILY: 12:00,15:30,17:3 0 HRS | SAME DAY |
| 10 | 3114C | ACE CSF | SPECTROPHOTOMETRY | CSF + CLINICAL HISTORY | 1.0 (0.5) ML | "R/F" | 1st & 3rd MON : 1200 HRS | SAME DAY |
| 11 | 0011LS | ACETONE, SERUM | BIOCHEMISTRY | SERUM | 1.0 ML (0.5ML) | "R" | DAILY: 1600 HRS | 3RD DAY |
| 12 | 1336 | ACETONE, URINE | CHEMICAL ANALYSIS | URINE | 10.0 ML (5.0 ML) | "R" | 1,3,5 : 1300 HRS | SAME DAY |
| 13 | 1411 | ACETYLCHOLINE RECEPTOR AUTOANTIBODIES | RADIO IMMUNOASSAY | SERUM / EDTA- PLASMA | 1.0 ML (0.5 ML) + 1.0 ML (0.5 ML) | "2-8 °C (7 days)" | 1,3,5: 1100 HRS | SAME DAY |
| 14 | 1464BA | ACID FAST BACILLI CULTURE ( HEP WHOLE BLOOD & / BONE MARROW) | BACTEC METHOD | WB-HEPARIN/ BONE MARROW INOCULATED IN MYCO F LYTIC BACTEC BOTTLE | 10.0 ML (5.0 ML) IN MYCO F/ LYTIC BACTEC BOTTLE | "A" | DAILY:1000 HRS | WK 6 (Or when culture positive) |
| 15 | 1464 | ACID FAST BACILLI CULTURE: MGIT | FLUORESCENT STAIN / ZIEHL NEELSEN STAIN & MGIT 960+LJ CULTURE | ANY SPECIMEN of Pulmonary Origin IN STERILE CONTAINER/ | 3.0 ML (2.0) ML | "R" | DAILY: 1000 HRS | SMEAR - 48 HOURS & WK 6 (Or when culture positive) |
| 16 | 1464EP | ACID FAST BACILLI CULTURE: MGIT | FLUORESCENT STAIN / ZIEHL NEELSEN STAIN & MGIT 960+LJ CULTURE | ANY SPECIMEN of Non-Pulmonary Origin (except Blood & Bone marrow) IN STERILE CONTAINER/ TISSUE IN S | 3.0 ML (2.0) ML / 1 TISSUE | "R" | DAILY: 1000 HRS | SMEAR - 48 HOURS & WK 6 (Or when culture positive) |
| 17 | 1465 | ACID FAST BACILLI MGIT CULTURE (WITHOUT IDENTIFICATION TEST) | FLUORESCENT STAIN / ZIEHL NEELSEN STAIN & MGIT 960+LJ CULTURE | ANY SPECIMEN IN STERILE CONTAINER/ WHOLE BLOOD HEPARIN / TISSUE IN STERILE NORMAL SALINE /SWABS ARE | 3.0 ML (2.0) ML / 1 TISSUE | "R" | DAILY ( MON TO SAT): 1000 HRS | SMEAR - 48 HOURS & WK 6 (Or when culture positive) |
| 18 | 1464S | ACID FAST BACILLI, STAIN & MGIT CULTURE (3 SAMPLES) | FLUORESCENT STAIN / ZIEHL NEELSEN STAIN & MGIT 960+LJ CULTURE | SPUTUM/ URINE- STERILE CONTAINER | 3.0ML (0.5 ML) / 10.0 ML (5.0 ML) | "R" | DAILY:1500 HRS | SMEAR - SAME DAY (Or after last specimen is received & wk6 or when culture is positive) |
| 19 | 1464U | ACID FAST BACILLI, STAIN & MGIT CULTURE (5 SAMPLES) | FLUORESCENT STAIN / ZIEHL NEELSEN STAIN & MGIT 960+LJ CULTURE | SPUTUM/ URINE- STERILE CONTAINER | 3.0ML (0.5 ML) / 10.0 ML (5.0 ML) | "R" | DAILY:1500 HRS | SMEAR - SAME DAY (Or after last specimen is received & wk6 or when culture is positive) |
| 20 | 5901 | ACTIVATED PROTEIN C RESISTANCE | CLOT BASED | FASTING, CITRATED PLATELET POOR PLASMA* - AT MINUS 20 ° C *(DOUBLE CENTRIFUGED PLASMA)* with CL | TWO ALIQOUTS OF 1.5 ML EACH | "F (To be F immediately at - 20 °c & transported in dry ice)" | WEND / SAT 11:00HRS | SAME DAY |
| 21 | 9940 | ACTN3 GENOTYPING | PCR-RFLP | EDTA WHOLE BLOOD/ BUCCAL SWAB | 5 ML (3ML)/ 2 SWABS | "A" | 5: 1030 HRS | 9TH DAY |
| 22 | 7756 | ACUTE HEPATITIS VIRUS EVALUATION I (HCV ABS, HEV IgM, HBsAg, HAV IgM, HBcore IgM) | Chemiluminescent Microparticle Immunoassay (CMIA) / ENZYME IMMUNOASSAY | SERUM | 3.0 ML (2.0 ML) | "2-8 °C (7 days) ,>7 days -20 °C" | DAILY: 0730 HRS & 1530 HRS, EXCEPT FOR HEV IgM. DAILY 1130 HRS | SAME DAY |
| 23 | 7755 | ACUTE HEPATITIS VIRUS EVALUATION II (HCV ABS, HEV IgM / IgG, HBsAg, HAV IgM, HBeAg, HBeAb) | Chemiluminescent Microparticle Immunoassay (CMIA) / ENZYME IMMUNOASSAY | SERUM | 3.0 ML (2.0 ML) | "2-8 °C (7 days) ,>7 days -20 °C" | DAILY: 0730 HRS & 1530 HRS, EXCEPT FOR HEV IgM. DAILY 1130 HRS; HEV IgG: 3:11:30HRS | SAME DAY |
| 24 | 7757 | ACUTE HEPATITIS VIRUS EVALUATION III (HSV IgM, CMV IgM, EBV (EA) IgG, VZV IgM) | ENZYME IMMUNOASSAY | SERUM | 3.0 ML (2.0 ML) | "2-8 °C (7 days) ,>7 days -20 °C" | HSV IgM, CMV IgM--- DAILY:03:00HRS; EBV (EA) IgG--- 2,5:1100 HRS; VZV IgM--- 3:1100HRS | SAME DAY |
| 25 | 1608 | ACUTE LEUKEMIA PANEL (CD10,CD19,CD20,CD22,CD3,CD5, CD7,CD13,CD33,CD34,CD117,HLA DR, CYTOPLASMIC MARK | FLOW CYTOMETRY | BM / WB- EDTA | BM / WB- HEPARIN | FLUID-EDTA I FLUID-HEPARIN I BM / WB / FLUIDS DIRECT SMEARS + CLI | 3-4 ML (1ML) / 3-4 ML (1ML) / 3-4 ML (1ML) / 3-4 ML (1 ML) | "A" | DAILY: 1530 HRS | NEXT DAY BY 6.00PM |
| 26 | 1606 | ACUTE LYMPHOBLASTIC LEUKEMIA PANEL (CD3,CD4,CD5,CD7,CD8,CD10,CD1 9,CD20,CD22,CD34,IgM, HLA-DR ,) | FLOW CYTOMETRY | BM / WB- EDTA | BM / WB- HEPARIN | FLUID-EDTA I FLUID-HEPARIN I BM / WB / FLUIDS DIRECT SMEARS + CLI | 3-4 ML (1ML) / 3-4 ML (1ML) / 3-4 ML (1ML) / 3-4 ML (1 ML) | "A" | DAILY: 1530 HRS | NEXT DAY BY 6.00PM |
| 27 | 1047 | ACUTE MYELOID LEUKEMIA (AML) PANEL (CD7, CD19, CD13, CD14, CD15, CD33, CD34, CD117, CD41, CD61, GLYC | FLOW CYTOMETRY | BM / WB- EDTA | BM / WB- HEPARIN | FLUID-EDTA I FLUID-HEPARIN I BM / WB / FLUIDS DIRECT SMEARS + CL | 3-4 ML (1ML) / 3-4 ML (1ML) / 3-4 ML (1ML) / 3-4 ML (1 ML) | "A" | DAILY:1530 HRS | NEXT DAY BY 6.00PM |
| 28 | 5840 | ACUTE PROMYELOCYTIC LEUKEMIA (APL) | CELL CULTURE | BONE MARROW-HEPARIN / HEPARIN -WB+ SMEAR + CLINICAL HISTORY [Please mention the CLINICAL HISTORY, bl | 3.0 ML (2.0 ML) + 1-2 REPRESENTATIVE SLIDES | "A" | DAILY:1200 HRS | 10 working days |
| 29 | Z217 | ADENOCARCINOMA V/S MALIGNANT MESOTHELIOMA (CEA, EMA, VIMENTIN, LWCK)[PHOTO] | IMMUNOHISTOCHEMISTRY | TISSUE IN 10%FORMALIN / PARAFIN BLOCK (Site of biopsy & Clinical details mandatory)MANDATORY IF TISS | 1 CM / 1 BLOCK | "A" | DAILY:1100 HRS | 3RD DAY |
| 30 | 3131 | ADENOSINE DEAMINASE (ADA) | SPECTROPHOTOMETRY | SERUM, PLEURAL FLUID, ASCITIC FLUID, CSF, PERICARDIAL FLUID, PERITONEAL FLUID & OTHER BODY FLUIDS ( | 1.0 (0.5) ML, 2.0 (1.0) ML, 2.0 (1.0), 2.0 (1.0) ML, 2.0 (1.0) ML | "F" | DAILY: 1200 HOURS | SAME DAY |
| 31 | 9921I | ADENOVIRUS IgG | ENZYME IMMUNOASSAY | SERUM | 0.50 ML (0.25 ML) | "2-8 °C (5 days); -70°C to - 20 °C (>5 days)" | 1ST FRI: 1030 HRS | NEXT DAY |
| 32 | 9924I | ADENOVIRUS IgM | ENZYME IMMUNOASSAY | SERUM | 0.50 ML (0.25 ML) | "2-8 °C (5 days); -70°C to - 20 °C (>5 days)" | 1ST FRI: 1030 HRS | NEXT DAY |
| 33 | 7589 | ADENOVIRUS PCR | POLYMERASE CHAIN REACTION | SWABS: (ORAL, EYE, NASAL) / RESPIRATORY FLUIDS | 1.0 (0.5) ML | "A" | 2:1000 HOURS | 5 : 1800 HRS |
| 34 | 9938RD | ADRB2 GENOTYPING FOR B-2- AGONIST RESPONSIVENESS | PCR-SEQUENCING | EDTA WHOLE BLOOD + CLINICAL HISTORY | 5 ML (3 ML) | "A" | 1: 1030 HRS | 6TH DAY |
| 35 | 9951U | ADRENALIN URINE | ELISA | RANDOM URINE / 24HRS URINE with (Preservative:10 - 15ML 6N HCL) & mention the TOTAL VOLUME. MIX THES | 10.0 ML | "F FROZEN STRICTLY" | 2nd & 4th WEDNESDAY : 1000HRS | NEXT DAY |
| 36 | 9951P | ADRENALIN, PLASMA | ELISA | THE BLOOD SAMPLE SHOULD BE STORED AT 2-8 DEGREE CELCIUS UNTIL CENTRIFUGED TO SEPARATE THE PLASMA WIT | 2.0 ML (1.0 ML) | "F FROZEN STRICTLY" | 2nd & 4th WEDNESDAY : 1000HRS | NEXT DAY |
| 37 | 3102 | ADRENOCORTICOTROPIC HORMONE (ACTH) - COMPLETE | CHEMILUMINESCENCE | PLASMA-EDTA ( Freeze the specimen immediately after separation. Specimen collected between 6-10 am i | 2.0 ML (0.5 ML) | "F" | 2,4: 0430,1430,1600 HRS | SAME DAY |
| 38 | Z161K | ADRENOCORTICOTROPIC HORMONE (ACTH) [PHOTO] | IMMUNOHISTOCHEMISTRY | TISSUE IN 10%FORMALIN / PARAFFIN BLOCK (Site of biopsy & Clinical details mandatory)MANDATORY IF TIS | 1 CM / 1 BLOCK | "A" | DAILY:1100 HRS | 3RD DAY |
| 39 | 3103 | ADRENOCORTICOTROPIC HORMONE (ACTH) STIMULATION TEST - 1 HOUR | CHEMILUMINESCENCE | 250ug Synacthen IM/IV 3 Serum Samples Collected 1/2 HR.Apart Basal (before drug) , 30min, 60min (Fre | 1.0 ML (0.5 ML) | "F" | DAILY: 0430,1430,1600 HRS | SAME DAY |
| 40 | 1212 | AEROBIC BLOOD CULTURE - BACTEC | BACTEC FLUORESCENT METHOD | WB- HEPARIN / INOCULATED BACTEC BOTTLE (AEROBIC PLUS ) | 5.0 ML (2.0 ML) | "A" | DAILY: 1700 HRS | PRELIM. 2ND DAY, FINAL 7TH DAY |
| 41 | 1221CS | AEROBIC CULTURE- ISOLATION & IDENTIFICATION (Culture + Sensitivity) | CULTURE + SENSITIVITY BY MIC BREAKPOINT | SCRAPINGS / PUS/ TISSUE IN SALINE-STERILE CONTAINER(Swabs not accepted) | SCRAPINGS / 3.0 ML (0.5 ML) | "R" | DAILY: 1700 HRS | 3RD DAY |
| 42 | 1212P | AEROBIC PAEDIATRIC CULTURE BLOOD- BACTEC | BACTEC FLUORESCENT METHOD | INOCULATED BACTEC BOTTLE (AEROBIC PLUS ) | 3.0 ML (0.5 ML) | "A" | DAILY: 1700 HRS | PRELIM. 2ND DAY, FINAL 7TH DAY |
| 43 | CA5654 | AFB SUSCEPTIBILITY : Capreomycin | BACTEC MGIT-960 METHOD | PURE FRESHLY SUB-CULTURED M. TUBERCULOSIS ISOLATE (ISOLATE IDENTIFICATION REPORT FROM THE REFERRING | PURE & FRESHLY SUBCULTURED M. TUBERCULOSIS COMPLEX ISOLATE (Isolate Identification report from the r | "R" | DAILY:1000 HRS | 15 DAYS |
| 44 | CI5654 | AFB SUSCEPTIBILITY : Ciprofloxacin | BACTEC MGIT-960 METHOD | PURE FRESHLY SUB-CULTURED M. TUBERCULOSIS ISOLATE (ISOLATE IDENTIFICATION REPORT FROM THE REFERRING | PURE & FRESHLY SUBCULTURED M. TUBERCULOSIS COMPLEX ISOLATE (Isolate Identification report from the r | "R" | DAILY:1000 HRS | 15 DAYS |
| 45 | ET5654 | AFB SUSCEPTIBILITY : Ethambutol | BACTEC MGIT-960 METHOD | PURE FRESHLY SUB-CULTURED M. TUBERCULOSIS ISOLATE (ISOLATE IDENTIFICATION REPORT FROM THE REFERRING | PURE & FRESHLY SUBCULTURED M. TUBERCULOSIS COMPLEX ISOLATE (Isolate Identification report from the r | "R" | DAILY:1000 HRS | 15 DAYS |
| 46 | EH5654 | AFB SUSCEPTIBILITY : Ethionamide | BACTEC MGIT-960 METHOD | PURE FRESHLY SUB-CULTURED M. TUBERCULOSIS ISOLATE (ISOLATE IDENTIFICATION REPORT FROM THE REFERRING | PURE & FRESHLY SUBCULTURED M. TUBERCULOSIS COMPLEX ISOLATE (Isolate Identification report from the r | "R" | DAILY 1000 HRS | 15 DAYS |
| 47 | IS5654 | AFB SUSCEPTIBILITY : Isoniazid | BACTEC MGIT-960 METHOD | PURE FRESHLY SUB-CULTURED M. TUBERCULOSIS ISOLATE (ISOLATE IDENTIFICATION REPORT FROM THE REFERRING | PURE & FRESHLY SUBCULTURED M. TUBERCULOSIS COMPLEX ISOLATE (Isolate Identification report from the r | "R" | DAILY:1000 HRS | 15 DAYS |
| 48 | KA5654 | AFB SUSCEPTIBILITY : Kanamycin | BACTEC MGIT-960 METHOD | PURE FRESHLY SUB-CULTURED M. TUBERCULOSIS ISOLATE (ISOLATE IDENTIFICATION REPORT FROM THE REFERRING | PURE & FRESHLY SUBCULTURED M. TUBERCULOSIS COMPLEX ISOLATE (Isolate Identification report from the r | "R" | DAILY:1000 HRS | 15 DAYS |
| 49 | LV5654 | AFB SUSCEPTIBILITY : Levofloxacin | BACTEC MGIT-960 METHOD | PURE FRESHLY SUB-CULTURED M. TUBERCULOSIS ISOLATE (ISOLATE IDENTIFICATION REPORT FROM THE REFERRING | PURE & FRESHLY SUBCULTURED M. TUBERCULOSIS COMPLEX ISOLATE (Isolate Identification report from the r | "R" | DAILY:1000 HRS | 15 DAYS |
| 50 | LZ5654 | AFB SUSCEPTIBILITY : LINEZOLID | BACTEC MGIT-960 METHOD | CULTURE | PURE & FRESHLY SUBCULTURED M. TUBERCULOSIS COMPLEX ISOLATE | "R" | DAILY:1000 HRS | 15 DAYS |